A method for improving the survival rate of a patient exposed to an endotoxin, the method comprising the step of administering tumor cytotoxic factor II intravenously, intramuscularly or subcutaneously to said patient in an amount effective to improve the survival rate of said patient, wherein {HEAD ~ the TCF II} is administered before or after said {TAIL ~ patient} is exposed to an endotoxin 
is administered after
A method for improving the survival rate of a patient exposed to an endotoxin , the method comprising the step of administering tumor cytotoxic factor II intravenously , intramuscularly or subcutaneously to said patient in an amount effective to improve the survival rate of said patient , wherein { HEAD ~ the TCF II } is administered before or after said { TAIL ~ patient } is exposed to an endotoxin
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL REL OTH OTH REL OTH TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH